INTRODUCTION
============

The endoplasmic reticulum (ER) lumen provides an environment for newly synthesized secretory proteins to fold properly and undergo posttranslational modifications to achieve their final native functional conformation. Disruption of protein folding can result in accumulation of unfolded proteins in the ER lumen that overwhelms its normal folding capacity, a condition characterized as ER stress. ER stress can be initiated by various circumstances, including overexpression of secretory proteins, inhibition of protein glycosylation, and change in redox state ([@B66]). Transduction of ER stress is signaled predominantly by the unfolded protein response (UPR), which works to restore ER homeostasis by simultaneously reducing protein load and increasing folding capacity within the ER ([@B75]). Alternative ER stress pathways have also been identified, including the ER surveillance pathway (ERSU), which delays ER inheritance until ER stress is resolved ([@B4]), and ER-associated degradation (ERAD), which retrotranslocates unfolded or misfolded proteins from the ER to the cytosol for proteasomal-targeted degradation ([@B50]). Furthermore, the ER membrane can undergo expansion according to cellular need via increased lipid biosynthesis, a process mediated by the Ino2/4 transcription factor complex ([@B62]).

ER stress elicits diverse and complex cellular responses, including intracellular signaling and changes in gene expression, and can stimulate both autophagy and apoptosis ([@B59]). For example, the UPR induces Ire1-dependent splicing of Hac1 mRNA to form an active transcription factor that enters the nucleus to increase expression of genes involved in lipid metabolism, cell wall biogenesis, and vesicular trafficking ([@B71]). In addition, the effect of ER stress extends to regulation of the vacuole, where it was reported that tunicamycin (Tm), a drug that induces ER stress by inhibition of N-linked glycosylation, results in changes in vacuolar morphology by inducing vacuolar fragmentation ([@B45]). Remarkably, the influence of ER stress on vacuolar structure and function has remained largely unexplored.

The yeast vacuole is analogous to the mammalian lysosome and functions in processes required for cellular homeostasis, including protein degradation, nutrient storage, and maintenance of cytoplasmic pH ([@B76]). Vacuolar morphology is regulated by the equilibrium between ­vacuolar fusion and fission activities ([@B2]; [@B47]). Under normal growth conditions, wild-type (WT) cells typically possess between one and four vacuoles, depending on the strain background ([@B6]). The balance between fusion and fission underlies the ability of vacuoles to rapidly alter their morphology in response to environmental conditions---for example, coalescing to form a single large vacuole under nutrient limitation versus fragmenting into numerous smaller vacuoles in response to hyperosmotic shock ([@B3]; [@B13]). Vacuolar fragmentation also occurs during cell cycle progression, where smaller vacuoles are partitioned for proper inheritance into the daughter cell ([@B76]). In both of these examples, fragmentation relies on increased levels of phosphatidylinositol 3,5-bisphosphate (PI(3,5)P~2~), a lipid that is enriched at the vacuole ([@B24], [@B25]; [@B13]; [@B76]). By contrast, a requirement for other fragmentation factors may depend on the specific inducing stimuli ([@B13]; [@B78]). For example, both the dynamin-like protein Vps1 and the vacuolar ATPase (V-ATPase) are required for osmotic stress--induced vacuolar fragmentation yet appear to be dispensable for fragmentation during cell cycle progression ([@B78]). Thus, whereas vacuolar fusion has been studied extensively and many of the required components have been identified and characterized, vacuole fission remains poorly understood.

Prior studies have revealed a role for target of rapamycin complex 1 (TORC1) in vacuolar fission during hyperosmotic stress ([@B51]). The TOR signaling network is a highly conserved regulator of cell growth that consists of two distinct protein complexes, TORC1 and TORC2, where TORC1 is uniquely inhibited by the macrolide drug rapamycin ([@B48]). The Tor1 and Tor2 kinases form the catalytic component of these protein complexes ([@B48]). TORC1 is composed of Tor1 or Tor2, Tco89, Kog1, and Lst8 and is enriched at the vacuolar membrane ([@B73]; [@B67]), where it regulates diverse cellular processes in response to both nutrient and stress conditions ([@B73]; [@B11]; [@B48]). Rapamycin treatment or deletion of the nonessential TORC1-specific component Tco89 results in inhibition of vacuolar fragmentation after hyperosmotic stress ([@B51]). By contrast, to date a role for TORC1 in ER stress-induced fragmentation has not been examined. Accordingly, in this study, we demonstrate a role for TORC1 in ER stress--induced vacuolar fragmentation. Furthermore, we carried out a forward genetic screen and identified several additional factors required for vacuolar fragmentation in response to ER stress.

RESULTS
=======

Examination of vacuolar morphology during ER stress
---------------------------------------------------

Results of a previous study demonstrated that in the presence of tunicamycin, WT cells contain fragmented vacuoles ([@B45]). To confirm these findings and determine whether this change in vacuolar morphology resulted strictly from Tm treatment or was a result of general ER stress, we examined vacuolar structure after treatment of cells with either Tm or dithiothreitol (DTT), a reducing agent that prevents disulfide bond formation and is an independent inducer of ER stress ([@B20]; [@B41]). The number of vacuoles per cell was counted, and cells containing five or more vacuoles were scored as fragmented, as previously described ([@B51]). Unstressed cells contained primarily a single vacuole per cell ([Figure 1A](#F1){ref-type="fig"}). As expected, a majority of cells treated with Tm displayed smaller and more numerous vacuoles, indicative of fragmentation ([Figure 1A](#F1){ref-type="fig"}). Similarly, the number of cells with fragmented vacuoles increased significantly upon treatment with DTT ([Figure 1A](#F1){ref-type="fig"}). The degree of fragmentation in DTT-treated cells was not as extensive as that seen with Tm, consistent with reports that reducing agents are not as robust an inducer of the UPR ([@B20]; [@B14]).

![ER stress results in vacuolar fragmentation. (A) WT (W303α) or *ero1-*1 cells were grown overnight at 30 and 25°C, respectively, to early log phase in YPD + 1 μM FM4-64. WT cells were then treated with DMSO (No Stress), 1 μg/ml Tm, or 25 μM DTT. (B) The *ero1-1* cells either remained at 25°C or were centrifuged and resuspended in 37°C YPD and incubated at 37°C for the indicated times. Cells were centrifuged and immediately visualized using fluorescence microscopy (spinning-disk confocal; Intelligent Imaging Innovations). Scale bar, 5 μm. The number of vacuoles per cell was counted (100 cells/condition) and categorized into one of three groups. The averages of three independent experiments are presented ± SEM.](4618fig1){#F1}

The kinetics of vacuolar fragmentation appeared similar to that of Hac1 mRNA splicing, a hallmark of UPR induction, for which maximum induction occurs at ∼2 h of treatment ([@B10]). In addition, we observed that re-formation of fewer and larger vacuoles after removal of Tm from cells required ∼7 h of growth in fresh medium (Supplemental Figure S1). Given that at least 4 h is required for ER stress to become resolved after removal of Tm ([@B10]), we conclude that vacuolar fragmentation both follows resolution of ER stress and requires conditions for new cell growth.

To extend these results and confirm that vacuolar fragmentation was not caused by off-target or nonspecific effects of Tm and/or DTT, we used a genetic approach to induce ER stress. Specifically, we examined the role of *ERO1*, encoding endoplasmic reticulum oxidoreductin 1, which catalyzes disulfide bond formation and isomerization within the ER, by inactivation of the temperature-sensitive *ero1-1* allele ([@B28]). We observed that vacuolar morphology was normal in *ero1-1* cells grown at the permissive temperature of 25°C but that vacuoles became fragmented when these cells were shifted to the nonpermissive temperature of 37°C ([Figure 1B](#F1){ref-type="fig"}). The kinetics of fragmentation was very similar to that observed using the chemical inducers, for which maximal effects were observed ∼2 h after the temperature shift. Together these results indicate that vacuolar fragmentation correlates with ER stress, as defined by Tm and DTT treatment and *ERO1* inactivation.

Vacuolar fragmentation is independent of known ER stress response pathways
--------------------------------------------------------------------------

To understand how ER stress influences vacuolar morphology, we assessed whether known pathways that are induced upon ER stress are involved in vacuolar fragmentation. We first tested whether the UPR was required for this response, which in yeast is initiated by the transmembrane kinase and endoribonuclease Ire1 ([@B65]; [@B54]). Accordingly, we examined vacuolar morphology in cells lacking Ire1 after Tm treatment, for which we observed that vacuoles in *ire1Δ* cells underwent fragmentation to the same extent as in WT cells ([Figure 2A](#F2){ref-type="fig"} and Supplemental Figure S2A), indicating that the UPR is not required for vacuolar fragmentation.

![Tm-induced vacuolar fission occurs independently of known ER stress response pathways. (A) *ire1Δ* (PLY1637) and isogenic WT (W303α) cells were grown at 30°C overnight in YPD + 1 μM FM4-64 to OD~600~ = 0.25 and then treated with DMSO or 1 μg/ml Tm for 2 h. Cells were centrifuged and immediately visualized using fluorescence microscopy. Vacuolar morphology was quantified as described in [Figure 1](#F1){ref-type="fig"}. The average of three independent experiments is shown ± SEM. (B--D) WT (BY4741), *slt2Δ*, *hrd1Δ*, and *ino4Δ* cells were grown and analyzed as in A.](4618fig2){#F2}

We next tested the ERSU pathway, which functions independently of the UPR through the MAP kinase Slt2 (Mpk1) to delay ER inheritance during ER stress ([@B4]). Specifically, we analyzed vacuolar morphology in *slt2Δ* cells after Tm treatment and observed that vacuolar fragmentation in *slt2Δ* cells was comparable to that for WT ([Figure 2B](#F2){ref-type="fig"} and Supplemental Figure S2B), indicating that ERSU is also not involved in this process.

We next examined involvement of ERAD, which requires the E3 ubiquitin ligase Hrd1 to ubiquitinate ERAD substrates and target them for degradation ([@B8]; [@B21]; [@B68]). We observed that vacuoles in *hrd1Δ* cells underwent vacuolar fragmentation to the same extent as in WT after treatment with Tm ([Figure 2C](#F2){ref-type="fig"} and Supplemental Figure S2B), excluding as well the involvement of ERAD in the regulation of vacuolar morphology.

Finally, we tested involvement of ER membrane expansion that occurs in response to ER stress, which accommodates an increased load of unfolded proteins. This expansion relies in part on the Ino2/4 transcription factor complex, which targets lipid biosynthetic genes ([@B62]). We examined the ability of vacuoles to fragment when membrane expansion was blocked by deletion of INO4. We observed that *ino4Δ* cells displayed fragmented vacuoles after ER stress, excluding this response as well ([Figure 2D](#F2){ref-type="fig"} and Supplemental Figure S2B). Together these data suggest that vacuolar morphology is regulated by ER stress via components that are distinct from known regulators of ER homeostasis.

Demonstrating a role for TORC1 in ER stress--mediated vacuolar fragmentation
----------------------------------------------------------------------------

Previous studies implicated TORC1 as a positive regulator of vacuolar fragmentation in response to hyperosmotic shock ([@B51]). Furthermore, rapamycin treatment inhibits TORC1 and promotes coalescence of vacuoles into a single large organelle ([@B17]; [@B26]; [@B51]). Accordingly, we tested whether TORC1 was required for ER stress--induced vacuolar fragmentation by simultaneously treating cells with Tm to induce ER stress, as well as with rapamycin, and analyzed vacuolar morphology. As expected, WT cells treated with Tm contained fragmented vacuoles, whereas cells treated with rapamycin maintained a single large vacuole ([Figure 3A](#F3){ref-type="fig"} and Supplemental Figure S3A). Of importance, fragmentation induced by Tm was blocked when TORC1 was inhibited by rapamycin, suggesting that TORC1 activity is required for ER stress--induced vacuolar fragmentation ([Figure 3A](#F3){ref-type="fig"} and Supplemental Figure S3A). Moreover, rapamycin treatment also blocked vacuolar fragmentation in temperature-shifted *ero1-1* cells, confirming the dependence of fragmentation on TORC1 activity ([Figure 3B](#F3){ref-type="fig"}).

![TORC1 is required for Tm-induced vacuolar fragmentation. (A) WT (W303α) cells were grown overnight as described in [Figure 1](#F1){ref-type="fig"}. Cells were treated with DMSO, 1 μg/ml Tm, 200 nM Rap, or both 1 μg/ml Tm and 200 nM Rap for 2 h, then centrifuged and immediately visualized using fluorescence microscopy. Quantification of vacuolar morphology was performed as described in [Figure 1](#F1){ref-type="fig"}. (B) ERO1 and *ero1-1* cells were grown at 25°C overnight in YPD + 1μM FM4-64 to OD~600~ = 0.25. Cells either remained at 25°C or were centrifuged and resuspended in 37°C YPD with either 200 nM Rap or 1 μg/ml Tm.](4618fig3){#F3}

Prior studies showed that TORC1 functions through at least two major downstream effector branches, defined by the proteins Tap42 and Sch9, to regulate a diverse array of cellular processes ([@B22]; [@B27]; [@B73]). We therefore tested whether either of these branches was required for vacuolar fragmentation. Because TAP42 is encoded by an essential gene, we used a temperature-sensitive allele, termed *tap42-106* ([@B27]), to examine vacuolar structure during ER stress at permissive versus nonpermissive temperatures. We observed that Tm-treated WT cells contained fragmented vacuoles at both the permissive temperature of 25°C and after a shift of cells to the nonpermissive temperature of 37°C ([Figure 4A](#F4){ref-type="fig"} and Supplemental Figure S3B). By contrast, we observed that whereas *tap42-106* cells displayed fragmented vacuoles after Tm treatment at 25°C, vacuoles remained nonfragmented in response to Tm at 37°C ([Figure 4A](#F4){ref-type="fig"} and Supplemental Figure S3B). These data indicate that the Tap42 branch of TORC1 is required for ER stress--induced vacuolar fragmentation. Tap42 has been proposed to interact with and regulate the activity of the type2A phosphatase Sit4 ([@B22]; [@B42]). Therefore we examined whether fragmentation occurred in Sit4-deficient cells. On treatment with Tm, *sit4Δ* cells were unable to undergo vacuolar fragmentation, indicating that Sit4 activity is also required for Tm-induced vacuolar fragmentation ([Figure 4B](#F4){ref-type="fig"} and Supplemental Figure S3C).

![TORC1 effectors are required for Tm-induced vacuolar fragmentation. (A) TAP42WT (PLY553) and *tap42ts-106* (PLY551) were grown overnight in SCD --Trp + 1 μM FM4-64 medium to OD~600~ = 0.25 at 25°C. Cells were incubated at either 25 or 37°C for 30 min and then treated with DMSO or 1 μg/ml Tm for 2 h and visualized using fluorescence microscopy. Vacuolar morphology was quantified as described in [Figure 1](#F1){ref-type="fig"}. (B, C) WT, *sit4Δ*, and *sch9Δ* (W303α, PLY1638, and PLY1639, respectively) cells were grown and treated, and vacuolar morphology was quantified as described in [Figure 1](#F1){ref-type="fig"}.](4618fig4){#F4}

We next examined the role of Sch9 in vacuolar fragmentation during ER stress. Sch9 is an AGC kinase and a likely orthologue of mammalian (S6K1) and has been implicated in the regulation of several activities downstream of TORC1, including cellular responses to osmotic and oxidative stresses ([@B73]). During Tm treatment, vacuolar fragmentation was blocked in *sch9Δ* cells ([Figure 4C](#F4){ref-type="fig"} and Supplemental Figure S3C), suggesting that Sch9 is also required for vacuolar fragmentation in response to ER stress. These data suggest that both the Tap42 and Sch9 effector branches are required downstream of TORC1 for ER stress--induced vacuolar fragmentation.

Because TORC1 is localized to the vacuole, we sought to determine whether this localization changed during vacuolar fragmentation. Accordingly, we examined the localization of functional green fluorescent protein (GFP)--tagged versions of the TORC1-specific components Tor1 and Tco89 after Tm treatment. Colocalization of GFP signal to the vacuolar membrane, marked by FM4-64, was quantified as described in *Materials and Methods*. On ER stress, the majority of Tor1-GFP and Tco89-GFP (75 and 85%, respectively) remained localized to the vacuolar membrane ([Figure 5](#F5){ref-type="fig"}) during vacuolar fragmentation. These findings suggest that TORC1 functions in vacuolar fission at the vacuolar membrane.

![TORC1 remains localized to the vacuolar membrane upon vacuolar fragmentation. Tor1GFP (PLY1176) and Tco89GFP (PLY1640) cells were grown overnight at 30°C to early log phase (OD~600~ = 0.25) in YPD + 1μM FM4-64 medium. Cells were treated with DMSO or 1 μg/ml Tm for 2 h, and then live cells were imaged using the spinning disk confocal microscope (Intelligent Imaging Innovations). Percentages indicate colocalization of GFP to FM4-64 signal as determined using Imaris software. Scale bar, 5 μm.](4618fig5){#F5}

Exploring the relationship between TORC1 and ER stress
------------------------------------------------------

To characterize further the relationship between ER stress and TORC1, we asked whether TORC1 and ER stress function independently or, alternatively, together within a linear pathway to influence vacuolar morphology ([Figure 6A](#F6){ref-type="fig"}). We reasoned that if ER stress functions upstream of TORC1, then Tm treatment might stimulate TORC1 activity, as proposed for activation of TORC1 by hyperosmotic stress ([@B51]). Alternatively, a study reported that Tm treatment results in decreased TORC1 activity ([@B46]). Accordingly, we used a previously established gel mobility shift assay to examine the behavior of the TORC1 pathway--specific target Npr1, which functions downstream of Tap42 and is phosphorylated in a rapamycin-sensitive manner ([@B61]; [@B29]; [@B33]). As a positive control for detecting increased TORC1 activity, we treated cells with sublethal doses of cycloheximide (CHX), a proposed activator of TORC1 ([@B9]; [@B73]). As expected, our results showed that Npr1 was both hyperphosphorylated after CHX treatment and dephosphorylated by rapamycin, confirming the utility of this assay ([Figure 6B](#F6){ref-type="fig"}). By contrast, no significant change in the mobility of Npr1 was detected after treatment of cells with Tm throughout the same time period that coincided with maximal vacuolar fragmentation ([Figure 6B](#F6){ref-type="fig"}).

![Evidence that ER stress and TORC1 are likely to act in parallel pathways to influence vacuolar morphology. (A) Model of vacuolar fragmentation depicting ER stress and TORC1 acting on vacuolar morphology in either (1) a parallel pathway or (2) a linear pathway. (B) Wild-type (W303α) cells expressing pr*^NPR1^*-NPR1-HA were grown in SCD --Trp medium containing DMSO (DM), Tm (1 μg/ml), Rap (200 ng), or CHX (25 μg/ml). Cells were analyzed at indicated time points by whole-cell extraction and Western blot analysis using anti-HA and anti-G6PDH antibodies. Quantification of the relative distribution of signal per lane was performed by measuring the level of signal in each portion of the lane---upper (hyperphosphorylated), center (phosphorylated), and lower (dephosphorylated)---and dividing each portion by the total amount of signal in the lane. Averages of three independent experiments are presented ± SEM. (C) WT (W303α) cells expressing HA-tagged Par32 were grown, treated, and subjected to Western blot analysis as described in B. Relative distribution of signal per lane was quantified as described in B.](4618fig6){#F6}

To extend these results, we used a similar gel shift mobility assay to examine the phosphorylation state of Par32, a distinct target downstream of TORC1/Tap42 that instead becomes hyperphosphorylated upon inhibition of TORC1activity by rapamycin treatment ([@B38]). As expected, we observed that Par32 mobility decreased after rapamycin treatment but saw no significant change in mobility after treatment with Tm ([Figure 6C](#F6){ref-type="fig"}). Finally, we examined a third TORC1-dependent substrate, Atg13, which is directly phosphorylated by TORC1 at multiple serine residues ([@B43]). Again, we observed predicted changes in mobility after treatment with rapamycin and CHX but no change with Tm (Supplemental Figure S4). On the basis of these results, we conclude that ER stress does not affect TORC1 activity, as measured using these approaches. Accordingly, we conclude that TORC1 is likely to function in a pathway that is parallel to ER stress in order to regulate vacuolar fragmentation.

A number of components have been proposed to act upstream of TORC1 and regulate its activity in yeast, in particular proteins that comprise the EGO complex, including Ego1 and Ego3, as well as Gtr1 and Gtr3, orthologues of the mammalian Rag 1-4 GTPases, which regulate mTORC1 activity ([@B26]; [@B30]; [@B44]; [@B60]; [@B11]; [@B77]). Precisely how these proteins regulate TORC1 activity in yeast remains ill defined ([@B30]; [@B77]; [@B55]). We examined the fragmentation behavior of mutants for each of these components and, unexpectedly, observed a variety of phenotypes (Supplemental Figure S5). For example, *ego3Δ* cells behaved most closely to what would be expected of a mutant within an upstream regulator of TORC1, where there was a strong block in vacuolar fragmentation after Tm treatment. By contrast, both *gtr1Δ* and *gtr2Δ* cells already displayed a significant number of cells that possessed fragmented vacuoles in the absence of Tm treatment and then became fully fragmented after drug treatment (Supplemental Figure S5). Finally, *ego1Δ* cells behaved like WT in that they displayed no fragmentation defect when treated with Tm (Supplemental Figure S5). We attribute this diversity in the response of these mutants to Tm to the complexity that likely exists in the upstream regulation of TORC1 in yeast.

Identification of factors required for ER stress--induced vacuolar fragmentation
--------------------------------------------------------------------------------

To further our understanding of processes that control vacuolar fission, we sought to identify additional components involved in transduction of ER-derived stress signals to the vacuole. Therefore we carried out an in vivo visual screen of the haploid yeast deletion collection of nonessential genes to identify mutants that displayed defects in vacuolar fragmentation in response to treatment with Tm. After an initial screen of the entire collection (∼5000 strains), mutants possessing at least 50% of cells with fragmentation defects were rearrayed and examined two additional times using high-throughput microscopy, where we included treatment with DTT in addition to Tm. Through this process, we identified 315 mutants that displayed reproducible fragmentation defects in response to ER stress ([Figure 7A](#F7){ref-type="fig"} and Supplemental Table S1). Of these candidates, mutants with the strongest phenotypes (\>70% cells containing nonfragmented vacuoles), along with 14 additional positive candidates involved in cellular signaling, were reexamined and subjected to a more rigorous individual inspection of vacuolar morphology (see *Materials and Methods*). Of these 77 strains, those that yielded cells containing mostly one or two vacuoles after treatment with Tm were considered the strongest candidates for further study ([Figure 7B](#F7){ref-type="fig"} and Supplemental Table S2).

![Genome-wide screen elucidates genes required for Tm-induced vacuolar fragmentation. (A) Manually defined functional categorization of 315 genes found to have a defect in vacuolar fragmentation upon Tm treatment. (B) Quantification of yeast deletion strains with the strongest defects in vacuolar fragmentation upon Tm treatment. Genes are manually grouped according to function. Genes depicted in A are listed in Supplemental Table S1.](4618fig7){#F7}

As expected, genes identified in our screen included factors determined previously to be required for fragmentation in response to hyperosmotic stress, including PI(3,5)P~2~ biosynthesis (Fab1, Vps15), components of the vacuolar ATPase (Vma3, Vma6), and members of the AP-3 adaptor complex (Aps3, Apl5, Apm3), as well as components involved in TORC1 signaling (Sit4, Vps9; [@B13]; [@B2]; [@B15]; [@B52]; [Figure 7B](#F7){ref-type="fig"} and Supplemental Table S1). In addition, our screen identified several new genes involved in vacuolar fragmentation that belong to virtually all functional groups (e.g., APL6, HIM1, and VPS15; [Figure 7B](#F7){ref-type="fig"} and Supplemental Table S2). Of interest, one new functional group consisted of genes, including VPH2 and VMA21, that are involved in V-ATPase assembly ([Figure 7B](#F7){ref-type="fig"}). Finally, our strongest hits included a number of genes that are unique to ER stress--induced fragmentation and encode proteins localized to the ER and Golgi (ATG8, EPS1, ALG9, GVP36), suggesting a potentially important role for the secretory pathway for this response (Supplemental Table S1).

Evidence that Vph2 provides a linkage between TORC1 and vacuolar fission
------------------------------------------------------------------------

To begin to explore the role of newly identified components in vacuolar fission, we assessed the intracellular localization of representative GFP-tagged proteins from each category of our strongest candidates ([Figure 7B](#F7){ref-type="fig"}), both in the absence and after treatment with Tm. Before drug treatment, all nine proteins displayed distinct localization patterns throughout the cell, consistent with previously published observations ([Figure 8A](#F8){ref-type="fig"}). For all but one of these candidates, no change in distribution was observed after Tm treatment, indicating their localization was not influenced by ER stress ([Figure 8A](#F8){ref-type="fig"}). The sole exception was Vph2, which was localized in a uniform manner throughout the ER in the absence of Tm but adopted a discontinuous punctate pattern within the ER after drug treatment ([Figure 8, A](#F8){ref-type="fig"} and [B](#F8){ref-type="fig"}). Because of the link we established between TORC1 signaling and vacuolar fragmentation, we asked whether this Tm-induced change in Vph2 localization was dependent on TORC1 activity. To test this, we examined Vph2 after simultaneous treatment of cells with both Tm and rapamycin and observed that rapamycin blocked completely the transition of Vph2 into a punctate localization pattern ([Figure 8B](#F8){ref-type="fig"}). Tm treatment did not affect the overall stability of the Vph2-GFP fusion protein used for this experiment, demonstrating that the punctate localization pattern was not due, for example, to the generation of free GFP (Supplemental Figure S6). We conclude from these findings that TORC1 activity is required for ER stress--catalyzed changes in Vph2 localization.

![ER stress elicits changes in Vph2GFP distribution. (A) Table indicating GFP localization of C-terminally tagged proteins from the yeast GFP collection. Strains were grown, treated with DMSO (DM) and Tm as described in [Figure 1](#F1){ref-type="fig"}, and imaged as described in [Figure 4](#F4){ref-type="fig"}. (B) Vph2GFP (BY4741) was grown overnight at 30°C to early log phase (OD~600~ = 0.25) in YPD + 1 μM FM4-64 medium, treated with DMSO, 1 μg/ml Tm, 200 nM Rap, or both 1 μg/ml Tm and 200 nM Rap for 2 h, and then centrifuged and immediately visualized using fluorescence microscopy. Vph2GFP cells containing dsRED-HDEL (PLY1641) were grown to early log phase, treated with DMSO, 1 μg/ml Tm, 200 nM Rap, or both 1 μg/ml Tm and 200 nM Rap for 2 h, and imaged as described in [Figure 4](#F4){ref-type="fig"}. Scale bar, 5 μm. GFP signal was scored as either ER localized (ER Tubular) or as punctate within the ER (ER Punctate). Averages of three independent experiments are presented ± SEM. Arrowheads show Vph2 puncta.](4618fig8){#F8}

Loss of Vph2 results in the Vma^−^ phenotype characteristic of V-ATPase mutants and includes defects in acidification of the vacuole ([@B56]; [@B5]; [@B37]; [@B40]; [@B35]). Indeed, Vph2 has been suggested to stabilize components of the V-ATPase and therefore aid in its assembly ([@B37]; [@B34]). Evidence exists that vacuolar acidification is required for fission ([@B2]; [@B45]); however, the precise role of the V-ATPase in vacuolar morphology has been somewhat controversial, with proposed roles in fusion that are distinct from a requirement for acidification alone ([@B7]; [@B69]). We therefore sought to determine the relationship between Vph2 and vacuolar pH with respect to ER stress--induced vacuolar fragmentation. First, we confirmed that a *vph2*Δ mutant possessed a strong acidification defect, based on its failure to grow at neutral pH, similar to the V-ATPase mutant *vma7*Δ ([Figure 9A](#F9){ref-type="fig"}). Growth of both strains was rescued by buffering the culture medium to pH 5.5, which correlated with WT levels of vacuolar acidification, as assayed using the fluorescent pH-reactive indicator dye 5(6)--carboxyfluorescein diacetate (CFDA; [Figure 9A](#F9){ref-type="fig"}, inset). Remarkably, despite this rescue in vacuolar acidification, however, we observed that both *vph2Δ* and *vma7Δ* cells remained blocked in vacuolar fission after treatment with Tm ([Figure 9B](#F9){ref-type="fig"}). These findings suggest that the function of Vph2, as well as of the V-ATPase in general, may include roles distinct from acidification to regulate ER stress--induced fragmentation.

![Vacuolar acidification does not restore *vph2Δ* vacuolar fragmentation defects. (A) WT (BY4741), *vph2Δ*, and *vma7Δ* cells were grown in YPD medium buffered to the indicated pH level with MES. Medium was inoculated at OD~600~ = 0.025 and grown overnight at 30°C for 16 h. Average measurement of the OD~600~ compared with WT in three independent experiments is presented ± SEM. Inset, percentage of cells with vacuolar CFDA staining after incubation in pH 5.5 YPD medium as described in D. (B) WT (BY4741), *vph2Δ*, and *vma7Δ* cells were grown overnight at 30°C to early log phase, and then 5 μM FM4-64 was added to the YPD medium and cells were incubated 1 h at 30°C. Cells were resuspended in fresh YPD, pH 5.5, medium containing DMSO or Tm (1 μg/ml) and incubated for 2 h at 30°C. CFDA, 10 μM, was added to the medium during the last 30 min. Cells were centrifuged, and vacuolar morphology and CFDA staining was assessed using fluorescence microscopy.](4618fig9){#F9}

DISCUSSION
==========

We combined genomic, biochemical, and cell biological approaches to explore the link between perturbation of ER homeostasis, induced by the protein misfolding agents Tm and DTT, and the process of vacuolar fragmentation. We determined that this link involves components and activities required for normal vacuolar function and morphology, including synthesis of PI(3,5)P~2~, the V-ATPase, the AP-3 clathrin-associated adaptor complex, and the class C core vacuole/endosome membrane tethering complex. Because many of these components have been shown to be required for vacuolar fission, we argue that ER stress is likely to interface with the vacuolar fission machinery to stimulate fragmentation. Remarkably, we determined that none of the canonical signaling pathways that respond to ER stress, including the UPR, ERAD, and ERSU pathways, is required for ER stress--induced vacuolar fragmentation, suggesting that a previously uncharacterized signaling pathway is involved in this process. In this regard, our demonstration of a requirement for TORC1, as well as two of its downstream effector arms, defined by Sch9 and Tap42/Sit4, respectively, is significant and indicates that TORC1 signaling plays an integral role in vacuolar morphology, for which we propose that TORC1 is likely to function in parallel with ER stress to regulate vacuolar fragmentation.

Our proposed role for TORC1 in ER stress--induced vacuolar fragmentation is consistent with previous findings that this complex is required for changes in vacuolar morphology in response to hyperosmotic stress ([@B51]). In particular, a system for recapitulating salt-sensitive vacuolar fragmentation in vitro demonstrated this process is sensitive to rapamycin, as well as to loss of the nonessential TORC1 subunit Tco89 ([@B51]). These authors found further that hyperosmotic shock--induced fragmentation was impaired in *sit4*Δ cells, consistent with our results that TORC1 functions through this phosphatase to influence vacuolar morphology. In contrast to our present findings, however, these authors did not observe a role for either Tap42 or Sch9, indicating there are likely to be important differences in the signaling requirements that link these two stress responses to changes in vacuolar morphology. We note that the kinetics of the two responses are also significantly different; salt-induced fragmentation occurs on a time scale of minutes, whereas ER stress requires ∼2 h for maximum fragmentation to occur. Moreover, a comparison of results of our genome-wide screen for mutants defective in ER stress--induced fragmentation and a similar screen that identified mutants defective in salt-induced fragmentation ([@B52]) reveals that there is an overlapping yet nonidentical set of components involved in these processes (Supplemental Table S2). Nevertheless, because there is significant overlap in genes identified in the two screens, it is likely that both ER stress and hyperosmotic stress converge on a core set of components required for vacuolar fission.

One of these components is Fab1, the PI 3-phosphate 5-kinase responsible for synthesis of PI(3,5)P~2~, a lipid that is enriched at the outer vacuolar membrane and is required for fission, the levels of which, moreover, increase after hyperosmotic stress ([@B24]; [@B18]; [@B13]). Of interest, a link between PI(3,5)P~2~ and TORC1 was reported in which an inverse correlation was observed between levels of this lipid and the sensitivity of cells to rapamycin ([@B16]). In addition, the TORC1-specific component Kog1, orthologue of the mammalian mTORC1 subunit Raptor, binds to PI(3,5)P~2~ at the vacuolar membrane ([@B16]). Thus it is possible that PI(3,5)P~2~ recruits TORC1 and/or its effectors to sites of vacuolar fission and thereby regulates the activity of substrates involved in fission. Alternatively, PI(3,5)P~2~ and TORC1 may alter the lipid environment of the vacuolar membrane to stimulate fission, where it has been reported that formation of lipid microdomains within the vacuolar membrane required both Fab1 and the activity of TORC1 ([@B70]). The substrate for Fab1 is PI 3-phosphate, which is produced by Vps34, the sole PI 3-kinase in yeast ([@B1]). Although this enzyme was not identified in our genomic screen, we subsequently examined *vps34*Δ cells and determined that there is a significant (∼30%) defect in ER stress--induced vacuolar fragmentation (unpublished observations). In addition, we observed a range of additional mild vacuolar morphology defects in *vps34*Δ cells both in the presence and absence of treatment with Tm, consistent with prior characterization of *vps34* as a class D *vps* mutant ([@B57]). We do not understand why *vps34*Δ cells possess a more mild fragmentation defect than *fab1*Δ cells, but this may be related to fact that PI 3-phosphate both is the precursor to the synthesis of PI(3,5)P~2~ and is involved directly in vacuolar fusion ([@B12]).

Our genome-wide screen also revealed a role for structural components of the V-ATPase, as well as two additional factors required for V-ATPase assembly, Vph2 and Vma21, in ER stress--induced vacuolar fragmentation. Previous studies demonstrated that the V-ATPase is required for vacuolar fragmentation during hyperosmotic stress, as well as for vacuolar fusion ([@B7]; [@B2]; [@B69]; [@B45]). What remains controversial, however, is whether the V-ATPase simply provides an acidified internal environment important for fission and/or fusion or might play a more fundamental mechanistic role in these processes ([@B72]; [@B7]; [@B19]). In this context, it is significant that although we were able to correct the vacuolar acidification defects associated with both Vph2 and Vma7, a component of the V1 domain of the V-ATPase, this was insufficient to restore ER stress--induced fragmentation within these cells. One possibility is that vacuolar acidification is necessary but not sufficient for fragmentation in response to ER stress and that the V-ATPase plays an additional role(s) important for changes in vacuolar morphology. Of importance, Tm treatment does not affect the distribution of V-ATPase subunits Vma6 and Vma7 at the vacuole ([Figure 8A](#F8){ref-type="fig"}), consistent with a requirement for the V-ATPase to be present at the vacuole during fragmentation.

In mammalian cells, the V-ATPase has been identified as a regulator of mTORC1 activation in response to amino acid availability ([@B79]). In particular, interactions between the V-ATPase and the p14 subunit of the Ragulator complex are proposed to modulate mTORC1 activity in response to amino acids ([@B79]). In this regard, it is relevant that our genomic screen identified Ego3 as being important for ER stress--induced vacuolar fragmentation (Supplemental Table S1 and Supplemental Figure S5).­­~­~ This protein is a subunit of the EGO complex and, like Ragulator, regulates TORC1 activity at the vacuolar membrane ([@B11]). Moreover, Ego3 forms a homodimer in a manner similar to the p14-MP1 heterodimer, and these components have been proposed to be functional homologues ([@B77]). Thus it is possible that the EGO complex, in particular the Ego3 subunit, is required for TORC1 activity in response to ER stress. However, as described earlier (Supplemental Figure S5), the behavior of other EGO complex mutants does not support such a role, suggesting that the activity of this complex in regulating TORC1 during vacuolar fragmentation would necessarily be complex.

Finally, our findings highlight the emerging importance of functional interactions between organelles and their roles in diverse cell biological processes. In many cases, these interactions are mediated by direct physical contact between membranes at distinct regions termed membrane contact sites ([@B36]). In particular, the vacuole is known to contact both the ER and the nuclear membrane at nucleus--vacuole junctions, which are important for piecemeal microautophagy at the nucleus, a process mediated by TORC1 ([@B58]). More recently, a novel contact site between the ER and the vacuole has been described that is required for formation of specific membrane domains that form in response to stress and include the TORC1-specific component Kog1 ([@B53]). Thus it is tempting to speculate that TORC1 may localize to ER--vacuole contact sites and that this may play a role in its regulation of changes in vacuolar morphology, including vacuolar fragmentation in response to ER stress.

MATERIALS AND METHODS
=====================

Yeast strains, plasmids, and media
----------------------------------

Yeast strains used in this study are listed in [Table 1](#T1){ref-type="table"}. Strains from the yeast haploid deletion collection ([@B31]) and the yeast GFP library ([@B39]) were used in indicated figure legends. Cells were grown in either rich YPD (2% yeast extract, 1% peptone, and 2% dextrose) or synthetic complete dextrose medium (0.8% yeast nitrogen base without amino acids, pH 5.5, 2% dextrose) supplemented with amino acids as described previously ([@B64]). The Npr1HA and Par32HA plasmids described by [@B33] and [@B38], respectively, were transformed into W303α cells using a previously described lithium acetate procedure ([@B32]). Deletion strains were constructed by knockout of the complete open reading frame with a selectable marker as previously described ([@B23]). TCO89 was endogenously tagged with GFP using the pKT127 (pFA6a--link--yEGFP--Kan) cassette described by [@B63]. To create PLY1641, TIPlac-dsRED-HDEL as described in [@B49] was linearized with *Eco*RV for integration and transformed into Vph2GFP (BY4741) from the GFP library ([@B39]).

###### 

*Saccharomyces cerevisiae* strains used in this study.

  Strain    Genotype                                                                                  Source
  --------- ----------------------------------------------------------------------------------------- ------------
  W303α     MATα ade2-1; leu2-3112; his3-11, 15; trp1-1; ura3-1; can1-100                             [@B81]
  PLY1637   W303α, except ire1::HIS3                                                                  This study
  PLY553    W303α, except tap42::HIS3 + \[pRS414 (CEN4 TRP1)-TAP42\]                                  [@B27]
  PLY551    W303α, except tap42::HIS3 + \[pRS414 (CEN4 TRP1)-tap42-106\]                              [@B27]
  PLY1638   W303α, except sit4::KANMX6                                                                This study
  PLY1639   W303α, except sch9::HIS3                                                                  This study
  PLY1640   W303α, TCO89-yEGFP-Kan                                                                    This study
  BY4741    his3Δ1; leu2Δ0; met15Δ0; ura3Δ0                                                           [@B80]
  TB50a     MATa leu2-3112 ura3-52 rme1 trp1 his3                                                     [@B67]
  PLY1176   MATa leu2-3112 ura3-52 rme1 trp1 his3 TOR1D330-3XGFP HMLa/pSH47 \[CEN URA3\]              [@B67]
  PLY1641   MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, Vph2GFP-His3MX6, dsRed-HDEL                            This study
  PLY1642   MATα, leu2-3112,trp1-1, can1-100, ura3-1, ade2-1, his3-11, bar1Δ::LEU2                    [@B4]
  PLY1643   MATα, leu2-3112,trp1-1, can1-100, ura3-1, ade2-1, his3-11,15, ero1-1::HIS3, bar1Δ::LEU2   [@B4]

Tunicamycin was dissolved in dimethyl sulfoxide (DMSO) and added to culture medium at a final concentration of 1 μg/ml. DTT (25 μM), rapamycin (200 nM), and cycloheximide (25 mg/ml) were dissolved in DMSO and added to culture medias as described in the respective figure legends. 5(6)-CFDA was added to culture medium to a final concentration of 10 μM after resuspension of cells in YPD, pH 5.5, medium buffered with 2-(*N*-morpholino)ethanesulfonic (MES) acid as described previously ([@B74]).

Vacuolar fragmentation assay
----------------------------

Vacuolar membrane labeling was done by growing cells overnight at 30°C to logarithmic phase (OD~600~ \< 1) in YPD or selective medium containing 1 μM FM4-64. Cells were adjusted to OD~600~ = 0.25 and then treated with drugs as described and incubated at 30°C for 2 h. Cells were pelleted by centrifugation, resuspended in residual medium, and imaged using fluorescence microscopy as described later. Vacuolar morphology was quantified by counting the number of vacuoles per cell (100 cells/condition), then grouped into three categories: cells containing 1--2, 3--4, or ≥5 vacuoles per cell, as described previously ([@B51]). Averages of three independent experiments are presented with ± SEM.

Whole-cell extraction, Western blot analysis, and quantification
----------------------------------------------------------------

Protein extracts were prepared using a NaOH cell lysis method ([@B23]), loaded onto SDS--PAGE gels, and transferred to nitrocellulose membrane. Membranes were probed with anti-hemagglutinin (HA; 1:5000; Sigma-Aldrich, St. Louis, MO), anti--glucose-6-phosphate dehydrogenase (G6PDH; Zwf1; 1:100,000; Sigma-Aldrich), or anti-GFP (1 μg/ml; N86/8; Neuromab, Davis, CA) primary antibodies and visualized using the appropriate secondary antibodies conjugated to IR Dye (1:5000; Li-COR Biosciences, Lincoln, NE). Quantifications were performed using ImageQuant software (GE Healthcare, Little Chalfont, UK). The relative distribution of the signal in each lane was figured by measuring the level of signal in three distinct portions of each lane---upper (hyperphosphorylated), center (phosphorylated), and lower (dephosphorylated)---and then dividing each portion by the total amount of signal within each lane.

Fluorescence microscopy
-----------------------

Strains containing fluorescently tagged proteins were labeled with FM4-64 as described and examined using the spinning-disk module of a Marianas SDC Real Time 3D Confocal-TIRF microscope (Intelligent Imaging Innovations, Denver, CO) fitted with a Yokogawa spinning-disk head, a 100×/1.46 numerical aperture objective, and an electron-multiplying charge-coupled device (EMCCD) camera. *Z*-stacks were taken at 0.4-μm increments over ∼6 μm of the cell. Images were processed using ImageJ software (National Institutes of Health, Bethesda, MD). Colocalization of GFP signal to FM4-64 was quantified using Imaris software (Bitplane, Concord, MA). The Manders coefficients are displayed. Assessment of vacuolar morphology and 5(6)-CFDA staining in strains without GFP-tagged proteins was performed using a Nikon E600 fluorescence microscope and an Orca ER CCD camera (Hamamatsu, Hamamatsu, Japan) controlled by Micro Manager 1.2 ImageJ software.

Genome-wide screen
------------------

Strains from the haploid deletion collection ([@B31]) were grown in 384-well plates overnight in YPD medium plus 1 μM FM4-64 at 30°C, then diluted 1:25 with fresh medium for 3 h to allow for logarithmic growth. YPD containing 1 μg/ml Tm was added to each well, and cells were incubated at 30°C for 90 min and then transferred to concanavalin A (0.25 mg/ml)--treated 384-well, glass-bottomed microscopy plates (Greiner Bio-One, Frickenhausen, Germany) for 15 min at ambient temperature. Cells were washed three times with YPD and imaged using the CellVoyager CV1000 confocal system, a 60× water immersion objective, and the back-illuminated EMCCD camera supplied with the unit (Yokogawa, Tokyo, Japan). Deletion strains with 50% or more of cells displaying a defect in vacuolar fragmentation (nonfragmented vacuoles) after the initial pass were rearrayed using a RoToR robot (Singer Instruments, Somerset, UK) to form a new library of candidate hits. This library was assayed twice more as described, after treatment with YPD containing DMSO, 1 μg/ml Tm, or 25 μM DTT. The defect in vacuolar fragmentation of each hit was judged by estimating the percentage of cells with nonfragmented vacuoles after Tm treatment, and then strains were grouped into one of three categories: cells containing 50--70, 70--90, or 90--100% nonfragmented vacuoles. Hits with \>50% of nonfragmented vacuoles (315) were manually grouped into 12 functional categories according to their involvement in cellular processes identified using the Saccharomyces Genome Database ([Figure 6A](#F6){ref-type="fig"}).

From the 315 identified hits, deletion strains with the strongest fragmentation defects (70--100% nonfragmented vacuoles) and 14 hits involved in cellular signaling were rearrayed to form a top-hits library containing 77 strains. Vacuolar morphology in this top-hits library was examined following DMSO, Tm, and DTT treatment as described, except that vacuolar structure was visualized using a Nikon Eclipse Ti with a 60× oil immersion 1.4 NA objective and Zyla sCMOS camera (Andor, Belfast, Northern Ireland) run by the Nikon high-content analysis package running inside Nikon Elements. The fragmentation defect in these strains was thoroughly quantified as described.
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CHX

:   cycloheximide

DMSO

:   dimethyl sulfoxide

DTT

:   dithiothreitol

ER

:   endoplasmic reticulum

ERAD

:   ER-associated degradation

ERSU

:   ER stress surveillance

PI(3,5)P~2~

:   phosphatidylinositol 3,5 bisphosphate

Rap

:   rapamycin

Tm

:   tunicamycin

TORC1

:   target of rapamycin complex 1

UPR

:   unfolded protein response
